Literature DB >> 21996676

Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma.

Yo-taro Shirai1, Shogo Ehata, Masakazu Yashiro, Kazuyoshi Yanagihara, Kosei Hirakawa, Kohei Miyazono.   

Abstract

A relationship exists between defects in bone morphogenetic protein (BMP) signaling and formation of hamartoma and adenoma in the gastric epithelium; however, the role of BMP signaling in the progression of diffuse-type gastric carcinoma remains unknown. We investigated whether BMP functions as a tumor suppressor in human diffuse-type gastric carcinoma using three different human diffuse-type gastric carcinoma cell lines (OCUM-12, HSC-39, and OCUM-2MLN). Overexpression of the dominant-negative form of BMP-2/4-specific type I receptor (ALK-3) in OCUM-12 and HSC-39 cells accelerated their growth in vivo. BMP-4 induced cell cycle arrest in these cells via p21 induction through the SMAD pathway. Moreover, overexpression of the constitutively active form of ALK-3 in HSC-39 and OCUM-2MLN cells suppressed the proliferation of these cells in vitro and in vivo. Our findings suggest that BMP-2 and BMP-4 function as potent tumor suppressors in diffuse-type gastric carcinoma.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21996676      PMCID: PMC3260801          DOI: 10.1016/j.ajpath.2011.08.022

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells.

Authors:  F Pouliot; C Labrie
Journal:  J Endocrinol       Date:  2002-01       Impact factor: 4.286

2.  Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells.

Authors:  S Ehata; E Johansson; R Katayama; S Koike; A Watanabe; Y Hoshino; Y Katsuno; A Komuro; D Koinuma; M R Kano; M Yashiro; K Hirakawa; H Aburatani; N Fujita; K Miyazono
Journal:  Oncogene       Date:  2010-12-06       Impact factor: 9.867

3.  BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.

Authors:  Hideyo Miyazaki; Tetsuro Watabe; Tadaichi Kitamura; Kohei Miyazono
Journal:  Oncogene       Date:  2004-12-16       Impact factor: 9.867

4.  Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.

Authors:  J R Howe; J L Bair; M G Sayed; M E Anderson; F A Mitros; G M Petersen; V E Velculescu; G Traverso; B Vogelstein
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

5.  Somatic frameshift mutations of bone morphogenic protein receptor 2 gene in gastric and colorectal cancers with microsatellite instability.

Authors:  Sang Wook Park; Soo Young Hur; Nam Jin Yoo; Sug Hyung Lee
Journal:  APMIS       Date:  2010-09-02       Impact factor: 3.205

6.  Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.

Authors:  Y Katsuno; A Hanyu; H Kanda; Y Ishikawa; F Akiyama; T Iwase; E Ogata; S Ehata; K Miyazono; T Imamura
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

7.  Context-dependent regulation of the expression of c-Ski protein by Arkadia in human cancer cells.

Authors:  Yoshiko Nagano; Daizo Koinuma; Keiji Miyazawa; Kohei Miyazono
Journal:  J Biochem       Date:  2009-12-02       Impact factor: 3.387

8.  Induction of prostaglandin E2 pathway promotes gastric hamartoma development with suppression of bone morphogenetic protein signaling.

Authors:  Hiroko Oshima; Hiraku Itadani; Hidehito Kotani; Makoto Mark Taketo; Masanobu Oshima
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

9.  Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma.

Authors:  M Ogawa; K Maeda; N Onoda; Y S Chung; M Sowa
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Family history and the risk of gastric cancer.

Authors:  M Yaghoobi; R Bijarchi; S A Narod
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

View more
  26 in total

1.  CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.

Authors:  Yo-Taro Shirai; Anna Mizutani; Saori Nishijima; Masafumi Horie; Chisato Kikuguchi; Olga Elisseeva; Tadashi Yamamoto
Journal:  Oncogene       Date:  2018-12-10       Impact factor: 9.867

2.  Anti-inflammatory activity of bone morphogenetic protein signaling pathways in stomachs of mice.

Authors:  Hidehiko Takabayashi; Masahiko Shinohara; Maria Mao; Piangwarin Phaosawasdi; Mohamad El-Zaatari; Min Zhang; Tuo Ji; Kathryn A Eaton; Duyen Dang; John Kao; Andrea Todisco
Journal:  Gastroenterology       Date:  2014-04-18       Impact factor: 22.682

3.  Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells.

Authors:  Jelena Mihajlović; Laura A M Diehl; Andreas Hochhaus; Joachim H Clement
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-17       Impact factor: 4.553

Review 4.  Bone Morphogenetic Proteins.

Authors:  Takenobu Katagiri; Tetsuro Watabe
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

5.  Cooperativity of E-cadherin and Smad4 loss to promote diffuse-type gastric adenocarcinoma and metastasis.

Authors:  Jun Won Park; Seok Hoon Jang; Dong Min Park; Na Jung Lim; Chuxia Deng; Dae Yong Kim; Jeffrey E Green; Hark Kyun Kim
Journal:  Mol Cancer Res       Date:  2014-04-30       Impact factor: 5.852

Review 6.  Regulation of bone morphogenetic protein 4 on epithelial tissue.

Authors:  Sitong Shen; Shurong Wang; Yuxi He; Huicong Hu; Boyuan Yao; Yan Zhang
Journal:  J Cell Commun Signal       Date:  2020-01-07       Impact factor: 5.782

7.  BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation.

Authors:  Bo Ram Kim; Sang Cheul Oh; Dae-Hee Lee; Jung Lim Kim; Suk Young Lee; Myoung Hee Kang; Sun Il Lee; Sanghee Kang; Sung Yup Joung; Byung Wook Min
Journal:  Tumour Biol       Date:  2015-06-30

8.  Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4.

Authors:  P Zhao; W Ma; Z Hu; Y Zhang; S Zhang; Y Wang
Journal:  J Endocrinol Invest       Date:  2018-02-13       Impact factor: 4.256

9.  Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway.

Authors:  Ying Zheng; Xuemei Wang; Haidong Wang; Wei Yan; Quan Zhang; Xin Chang
Journal:  Tumour Biol       Date:  2014-02-27

Review 10.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.